The Peripheral Artery Disease (PAD) market offers a comprehensive portfolio of diagnostic and therapeutic products designed to detect and treat occlusive arterial conditions in the lower extremities. Diagnostic equipment such as duplex ultrasound systems, CT angiography, and magnetic resonance angiography provide high-resolution imaging for accurate lesion identification, enabling clinicians to tailor interventions with precision. Interventional devices—including percutaneous transluminal angioplasty balloons, drug-coated balloons, vascular stents, and atherectomy catheters—deliver minimally invasive treatment options that reduce recovery times, lower complication rates, and improve patient outcomes.

The integration of smart sensors and real-time imaging further enhances procedural accuracy and optimizes clinical workflows. Growing Peripheral Artery Disease Marketprevalence, driven by diabetes, hypertension, and smoking, has amplified the need for advanced therapies, presenting significant market opportunities. Manufacturers are focusing on R&D investments, strategic partnerships, and expanded distribution networks to capture a larger market share. Market segments across diagnostics, interventional devices, and supportive care are poised for robust growth, supported by favorable reimbursement policies and evolving market trends toward outpatient procedures.

The Peripheral Artery Disease (PAD) Market is estimated to be valued at USD 4.31 Billion in 2025 and is expected to reach USD 6.74 Billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.

Key Takeaways
Key players operating in the Peripheral Artery Disease (PAD) Market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cook Medical, and Becton, Dickinson and Company.

These market companies have established robust product portfolios encompassing cutting-edge diagnostic platforms, drug-coated balloons, peripheral stents, and atherectomy systems. Abbott Laboratories leverages its R&D capabilities to introduce next-generation drug-eluting devices, strengthening its market share in North America and Europe.

‣ Get more insights on : Peripheral Artery Disease (PAD) Market

‣ Get this Report in Japanese Language: 末梢動脈疾患（PAD）市場

‣ Get this Report in Korean Language: 말초동맥질환(PAD)시장